Literature DB >> 27895154

Kidney Tubular Ablation of Ocrl/Inpp5b Phenocopies Lowe Syndrome Tubulopathy.

Kazunori Inoue1, Daniel M Balkin2,3,4, Lijuan Liu2,3,4,5, Ramiro Nandez2,3,4, Yumei Wu2,3,4,5, Xuefei Tian1, Tong Wang6, Robert Nussbaum7,8,3, Pietro De Camilli9,3,4,5, Shuta Ishibe10,6.   

Abstract

Lowe syndrome and Dent disease are two conditions that result from mutations of the inositol 5-phosphatase oculocerebrorenal syndrome of Lowe (OCRL) and share the feature of impaired kidney proximal tubule function. Genetic ablation of Ocrl in mice failed to recapitulate the human phenotypes, possibly because of the redundant functions of OCRL and its paralog type 2 inositol polyphosphate-5-phosphatase (INPP5B). Germline knockout of both paralogs in mice results in early embryonic lethality. We report that kidney tubule-specific inactivation of Inpp5b on a global Ocrl-knockout mouse background resulted in low molecular weight proteinuria, phosphaturia, and acidemia. At the cellular level, we observed a striking impairment of clathrin-dependent and -independent endocytosis in proximal tubules, phenocopying what has been reported for Dent disease caused by mutations in the gene encoding endosomal proton-chloride exchange transporter 5. These results suggest that the functions of OCRL/INPP5B and proton-chloride exchange transporter 5 converge on shared mechanisms, the impairment of which has a dramatic effect on proximal tubule endocytosis.
Copyright © 2017 by the American Society of Nephrology.

Entities:  

Keywords:  INPP5B; Lowe syndrome; OCRL; endocytosis; proximal tubulopathy

Mesh:

Substances:

Year:  2016        PMID: 27895154      PMCID: PMC5407733          DOI: 10.1681/ASN.2016080913

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  51 in total

1.  Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy.

Authors:  Susan P Bothwell; Emily Chan; Isa M Bernardini; Yien-Ming Kuo; William A Gahl; Robert L Nussbaum
Journal:  J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 10.121

2.  Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.

Authors:  P A Jänne; S F Suchy; D Bernard; M MacDonald; J Crawley; A Grinberg; A Wynshaw-Boris; H Westphal; R L Nussbaum
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

3.  Rab35 GTPase Triggers Switch-like Recruitment of the Lowe Syndrome Lipid Phosphatase OCRL on Newborn Endosomes.

Authors:  Clothilde Cauvin; Morgane Rosendale; Neetu Gupta-Rossi; Murielle Rocancourt; Pierre Larraufie; Rémi Salomon; David Perrais; Arnaud Echard
Journal:  Curr Biol       Date:  2015-12-24       Impact factor: 10.834

4.  Disrupted sperm function and fertilin beta processing in mice deficient in the inositol polyphosphate 5-phosphatase Inpp5b.

Authors:  E Hellsten; J P Evans; D J Bernard; P A Jänne; R L Nussbaum
Journal:  Dev Biol       Date:  2001-12-15       Impact factor: 3.582

Review 5.  Toward understanding renal Fanconi syndrome: step by step advances through experimental models.

Authors:  Christophe Sirac; Frank Bridoux; Marie Essig; Olivier Devuyst; Guy Touchard; Michel Cogné
Journal:  Contrib Nephrol       Date:  2011-01-20       Impact factor: 1.580

6.  Membrane targeting and activation of the Lowe syndrome protein OCRL1 by rab GTPases.

Authors:  Noora Hyvola; Aipo Diao; Eddie McKenzie; Alison Skippen; Shamshad Cockcroft; Martin Lowe
Journal:  EMBO J       Date:  2006-08-10       Impact factor: 11.598

Review 7.  Renal tubule albumin transport.

Authors:  Michael Gekle
Journal:  Annu Rev Physiol       Date:  2005       Impact factor: 19.318

8.  Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction.

Authors:  Detlef Bockenhauer; Arend Bokenkamp; William van't Hoff; Elena Levtchenko; Joana E Kist-van Holthe; Velibor Tasic; Michael Ludwig
Journal:  Clin J Am Soc Nephrol       Date:  2008-05-14       Impact factor: 8.237

9.  The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone.

Authors:  D Bacic; M Lehir; J Biber; B Kaissling; H Murer; C A Wagner
Journal:  Kidney Int       Date:  2006-02       Impact factor: 10.612

10.  A role of OCRL in clathrin-coated pit dynamics and uncoating revealed by studies of Lowe syndrome cells.

Authors:  Ramiro Nández; Daniel M Balkin; Mirko Messa; Liang Liang; Summer Paradise; Heather Czapla; Marco Y Hein; James S Duncan; Matthias Mann; Pietro De Camilli
Journal:  Elife       Date:  2014-08-08       Impact factor: 8.140

View more
  13 in total

Review 1.  The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.

Authors:  Maria Antonietta De Matteis; Leopoldo Staiano; Francesco Emma; Olivier Devuyst
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

Review 2.  The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease.

Authors:  Ana Raquel Ramos; Somadri Ghosh; Christophe Erneux
Journal:  J Lipid Res       Date:  2018-09-07       Impact factor: 5.922

Review 3.  Phosphoinositides in the kidney.

Authors:  Leopoldo Staiano; Maria Antonietta De Matteis
Journal:  J Lipid Res       Date:  2018-10-12       Impact factor: 5.922

4.  Incomplete cryptic splicing by an intronic mutation of OCRL in patients with partial phenotypes of Lowe syndrome.

Authors:  Eiji Nakano; Amine Yoshida; Yudai Miyama; Tomoo Yabuuchi; Yuko Kajiho; Shoichiro Kanda; Kenichiro Miura; Akira Oka; Yutaka Harita
Journal:  J Hum Genet       Date:  2020-05-19       Impact factor: 3.172

5.  Effects of Proximal Tubule Shortening on Protein Excretion in a Lowe Syndrome Model.

Authors:  Megan L Gliozzi; Eugenel B Espiritu; Katherine E Shipman; Youssef Rbaibi; Kimberly R Long; Nairita Roy; Andrew W Duncan; Matthew J Lazzara; Neil A Hukriede; Catherine J Baty; Ora A Weisz
Journal:  J Am Soc Nephrol       Date:  2019-11-01       Impact factor: 10.121

6.  Molecular Control of Phosphorus Homeostasis and Precision Treatment of Hypophosphatemic Disorders.

Authors:  Thomas J Weber; L Darryl Quarles
Journal:  Curr Mol Biol Rep       Date:  2019-02-09

Review 7.  Phosphoinositides in autophagy: current roles and future insights.

Authors:  Lavinia Palamiuc; Archna Ravi; Brooke M Emerling
Journal:  FEBS J       Date:  2019-11-21       Impact factor: 5.622

8.  A 3D Renal Proximal Tubule on Chip Model Phenocopies Lowe Syndrome and Dent II Disease Tubulopathy.

Authors:  Sindhu Naik; Andrew R Wood; Maté Ongenaert; Paniz Saidiyan; Edo D Elstak; Henriëtte L Lanz; Jan Stallen; Richard Janssen; Elizabeth Smythe; Kai S Erdmann
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

9.  Transcriptome analysis of neural progenitor cells derived from Lowe syndrome induced pluripotent stem cells: identification of candidate genes for the neurodevelopmental and eye manifestations.

Authors:  Hequn Liu; Jesse Barnes; Erika Pedrosa; Nathaniel S Herman; Franklin Salas; Ping Wang; Deyou Zheng; Herbert M Lachman
Journal:  J Neurodev Disord       Date:  2020-05-11       Impact factor: 4.025

10.  OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease.

Authors:  Beatrice Paola Festa; Marine Berquez; Alkaly Gassama; Irmgard Amrein; Hesham M Ismail; Marijana Samardzija; Leopoldo Staiano; Alessandro Luciani; Christian Grimm; Robert L Nussbaum; Maria Antonietta De Matteis; Olivier M Dorchies; Leonardo Scapozza; David Paul Wolfer; Olivier Devuyst
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.